INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR HAVE A ROLE IN TUMOR REGRESSIONS MEDIATED BY MURINE CD8+ TUMOR-INFILTRATING LYMPHOCYTES

被引:427
作者
BARTH, RJ [1 ]
MULE, JJ [1 ]
SPIESS, PJ [1 ]
ROSENBERG, SA [1 ]
机构
[1] NCI, SURG BRANCH, BLDG 10, ROOM 2B46, BETHESDA, MD 20892 USA
关键词
D O I
10.1084/jem.173.3.647
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have investigated the mechanisms whereby adoptively transferred murine CD8+ lymphocytes mediate tumor regressions. Noncytolytic, CD8+ tumor-infiltrating lymphocytes (TIL) eradicated established lung tumors in irradiated mice. Many cytolytic and noncytolytic CD8+ TIL cultures specifically secreted interferon-gamma (IFN-gamma) and tumor necrosis factor when stimulated with tumor cells in vitro. The effectiveness of TIL when adoptively transferred to mice bearing micrometastases correlated better with their ability to specifically secrete lymphokines than with their cytotoxicity in vitro. In 14 of 15 tests, therapeutically effective TIL specifically secreted IFN-gamma in vitro, whereas only 1 of 11 ineffective TIL specifically secreted IFN-gamma. In contrast, only 8 of 15 therapeutically effective TIL were cytolytic. Antibodies to TNF inhibited the effectiveness of two adoptively transferred TIL cultures. In five experiments, antibodies to IFN-gamma abrogated the ability of four different CD8+ TIL cultures to mediate tumor regressions, indicating that secretion of IFN-gamma is an essential part of the mechanism of action of TIL.
引用
收藏
页码:647 / 658
页数:12
相关论文
共 48 条
[11]  
FONG TAT, 1989, J IMMUNOL, V143, P2887
[12]  
FOX BA, 1990, J BIOL RESP MODIF, V9, P499
[13]   PASSIVE-IMMUNIZATION AGAINST TUMOR NECROSIS FACTOR PARTIALLY ABROGATES INTERLEUKIN-2 TOXICITY [J].
FRAKER, DL ;
LANGSTEIN, HN ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :1015-1020
[14]  
FUJIWARA H, 1984, J IMMUNOL, V133, P1671
[15]  
GAJEWSKI TF, 1990, J IMMUNOL, V144, P548
[16]  
GIOVARELLI M, 1988, J IMMUNOL, V141, P2831
[17]   ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY CHEMO-IMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE AND ADOPTIVELY TRANSFERRED IMMUNE SYNGENEIC LYMPHOCYTES-LYT-1+2- [J].
GREENBERG, PD ;
CHEEVER, MA ;
FEFER, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) :952-963
[18]   THERAPY OF DISSEMINATED MURINE LEUKEMIA WITH CYCLOPHOSPHAMIDE AND IMMUNE LYT-1+,2- T-CELLS - TUMOR-ERADICATION DOES NOT REQUIRE PARTICIPATION OF CYTO-TOXIC T-CELLS [J].
GREENBERG, PD ;
KERN, DE ;
CHEEVER, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :1122-1134
[19]  
GREENBERG PD, 1986, J IMMUNOL, V136, P1917
[20]  
GUERNE PA, 1984, J IMMUNOL, V132, P1869